Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMLD8DF)

Drug Name	MK-1942 DMLD8DF
Drug Type	Small molecule

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Depression	DIS3XJ69	6A70-6A7Z	Phase 2	[1]
Alzheimer disease	DISF8S70	8A20	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04663321) A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression. U.S.National Institutes of Health.
2	ClinicalTrials.gov (NCT05602727) A Phase 2a/2b Randomized, Placebo-Controlled Clinical Study To Evaluate The Safety And Efficacy Of MK-1942 As Adjunctive Therapy In Participants With Mild To Moderate Alzheimer's Disease Dementia. U.S.National Institutes of Health.